Home :: Tag Archives: AbbVie’s Humira and Roche’s Herceptin

Tag Archives: AbbVie’s Humira and Roche’s Herceptin

Biosimilar drugs could save up to US$110 billion by 2020: IMS

LONDON: Lower-cost copies of complex biotech drugs, known as biosimilars, could save the United States and Europe’s five top markets as much as 98 billion euros (US$110 bln) by 2020, a new analysis showed on Tuesday. Realizing those savings, however, depends on effective doctor education and healthcare providers adopting smart market access strategies, the report by IMS Institute for Healthcare ...

Read More »